<?xml version="1.0" encoding="UTF-8"?>
<pub-one-record-set xmlns:p1="http://pubmed.gov/pub-one"
  xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
  <pub-one-record p1:bookid="book_132404" p1:id="book_132404" p1:pmid="pubmed_23420913"
    record-type="chapter" xml:lang="eng">
    <source-meta>
      <object-id pub-id-type="iso-abbrev">Pediatrics</object-id>
      <object-id pub-id-type="nlm-ta">Pediatrics</object-id>
      <object-id pub-id-type="nlm-journal-id">0376422</object-id>
      <object-id pub-id-type="pmcbook-name">dare</object-id>
      <object-id pub-id-type="pmcbookid">NBK285222</object-id>
      <title-group>
        <title>Pediatrics</title>
      </title-group>
      <issn publication-format="electronic">1098-4275</issn>
      <issn-l>0031-4005</issn-l>
      <pub-date date-type="epubr" iso-8601-date="1995">
        <year>1995</year>
      </pub-date>
      <publisher>
        <publisher-name>Centre for Reviews and Dissemination (UK)</publisher-name>
        <publisher-loc>York (UK)</publisher-loc>
      </publisher>
      <permissions>
        <copyright-statement>Copyright Â© 2014 University of York</copyright-statement>
      </permissions>
    </source-meta>
    <document-meta>
      <object-id pub-id-type="pmid">23420913</object-id>
      <object-id pub-id-type="pii">peds.2012-2121</object-id>
      <object-id pub-id-type="doi">10.1542/peds.2012-2121</object-id>
      <object-id pub-id-type="pmcbookid">NBK132404</object-id>
      <object-id pub-id-type="pmcaiid">132404</object-id>
      <subj-group subj-group-type="publication-type">
        <subject>Journal Article</subject>
        <subject>Meta-Analysis</subject>
        <subject>Review</subject>
      </subj-group>
      <title-group>
        <title>NIDCAP: a systematic review and meta-analyses of randomized controlled trials</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ohlsson</surname>
            <given-names initials="A">Arne</given-names>
          </name>
          <aff>Department of Paediatrics, University of Toronto, Ontario, Canada.
            aohlsson@mtsinai.on.ca</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jacobs</surname>
            <given-names initials="SE">Susan E</given-names>
          </name>
        </contrib>
      </contrib-group>
      <volume>131</volume>
      <issue>3</issue>
      <fpage>e881</fpage>
      <lpage>e893</lpage>
      <pub-history>
        <date date-type="entrez" iso-8601-date="20130220T060000">
          <day>20</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date date-type="pubmed" iso-8601-date="20130220T060000">
          <day>20</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date date-type="medline" iso-8601-date="20130504T060000">
          <day>4</day>
          <month>5</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-article ext-link-type="pubmed" id="d8586e4870" page="e550"
        related-article-type="commentary" vol="132" xlink:href="23908320">Pediatrics. 2013
        Aug;132(2):e550</related-article>
      <abstract>
        <sec>
          <title>Background and objective</title>
          <p>The "synactive" theory of neurobehavioral development forms the basis of the Newborn
            Individualized Developmental Care and Assessment Program (NIDCAP). Our objective was to
            assess the effectiveness of NIDCAP in improving outcomes in preterm infants.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Medline, CINAHL, Embase, PsychInfo, The Cochrane Library, Pediatric Academic Societies'
            Abstracts and Web of Science were searched in July 2010 and February 2012. The studies
            selected were randomized controlled trials testing the effectiveness of NIDCAP on
            medical and neurodevelopmental outcomes. The authors abstracted baseline characteristics
            of infants and outcomes. The risk of bias was assessed by using Cochrane criteria.
            RevMan 5.1 was used to synthesize data by the use of relative risk and risk difference
            for dichotomous outcomes and mean or standardized mean difference for continuous
            outcomes.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Eleven primary and 7 secondary studies enrolling 627 neonates were included, with 2 of
            high quality. The composite primary outcomes of death or major sensorineural disability
            at 18 months corrected age or later in childhood (3 trials, 302 children; relative risk
            0.89 [95% confidence interval 0.61 to 1.29]) and survival free of disability at 18
            months corrected age or later in childhood (2 trials, 192 infants; relative risk 0.97
            [95% confidence interval 0.69 to 1.35]), were not significantly different between the
            NIDCAP and control groups. With the sensitivity analysis that excluded the 2
            statistically heterogeneous outlying studies, there were no significant differences
            between groups for short-term medical outcomes.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This systematic review including 627 preterm infants did not find any evidence that
            NIDCAP improves long-term neurodevelopmental or short-term medical outcomes.</p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="MeshHeadingList">
        <nested-kwd>
          <kwd content-type="not-major">Child Development</kwd>
          <nested-kwd>
            <kwd content-type="major">physiology</kwd>
          </nested-kwd>
        </nested-kwd>
        <kwd content-type="not-major">Humans</kwd>
        <kwd content-type="not-major">Infant, Newborn</kwd>
        <nested-kwd>
          <kwd content-type="not-major">Infant, Premature</kwd>
          <nested-kwd>
            <kwd content-type="major">growth &amp; development</kwd>
          </nested-kwd>
        </nested-kwd>
        <nested-kwd>
          <kwd content-type="not-major">Neonatal Screening</kwd>
          <nested-kwd>
            <kwd content-type="major">methods</kwd>
            <kwd content-type="not-major">standards</kwd>
          </nested-kwd>
        </nested-kwd>
        <nested-kwd>
          <kwd content-type="not-major">Program Evaluation</kwd>
          <nested-kwd>
            <kwd content-type="not-major">methods</kwd>
            <kwd content-type="not-major">standards</kwd>
          </nested-kwd>
        </nested-kwd>
        <nested-kwd>
          <kwd content-type="not-major">Randomized Controlled Trials as Topic</kwd>
          <nested-kwd>
            <kwd content-type="not-major">methods</kwd>
            <kwd content-type="not-major">standards</kwd>
          </nested-kwd>
        </nested-kwd>
      </kwd-group>
      <kwd-group kwd-group-type="document-languages">
        <kwd>eng</kwd>
      </kwd-group>
      <notes notes-type="sections">
        <sec id="dare__d12013017334__d12013017334_abs" sec-type="object">
          <title>Abstract</title>
        </sec>
      </notes>
    </document-meta>
  </pub-one-record>
</pub-one-record-set>
